✦ LIBER ✦

The French randomized optimal stenting trial: a prospective evaluation of provisional stenting guided by coronary velocity reserve and quantitative coronary angiography

✍ Scribed by Antoine Lafont; Jean L Dubois-Randé; Philippe G Steg; Patrick Dupouy; Didier Carrié; Pierre Coste; Alain Furber; Farzin Beygui; Laurent J Feldman; Saliha Rahal; Christophe Tron; Martial Hamon; Gilles Grollier; Philippe Commeau; Pascal Richard; Patrice Colin; Christophe Bauters; Gaetan Karrillon; François Ledru; Bernard Citron; François Noel Marié; Morton Kern

Book ID: 119541614
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 154 KB
Volume: 36
Category: Article
ISSN: 1558-3597
DOI: 10.1016/s0735-1097(00)00747-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A prospective, randomized trial of intra

A prospective, randomized trial of intravascular-ultrasound guided compared to angiography guided stent implantation in complex coronary lesions: The AVIO trial

✍ Alaide Chieffo; Azeem Latib; Christophe Caussin; Patrizia Presbitero; Stefano Ga 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 515 KB

Clinical and Angiographic Outcomes After

Clinical and Angiographic Outcomes After Treatment of De Novo Coronary Stenoses With a Novel Platinum Chromium Thin-Strut Stent: Primary Results of the PERSEUS (Prospective Evaluation in a Randomized Trial of the Safety and Efficacy of the Use of the TAXUS Element Paclitaxel-Eluting Coronary Stent System) Trial

✍ Dean J. Kereiakes; Louis A. Cannon; Robert L. Feldman; Jeffrey J. Popma; Raymond 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 829 KB

ABSORB II randomized controlled trial: A

ABSORB II randomized controlled trial: A clinical evaluation to compare the safety, efficacy, and performance of the Absorb everolimus-eluting bioresorbable vascular scaffold system against the XIENCE everolimus-eluting coronary stent system in the treatment of subjects with ischemic heart disease caused by de novo native coronary artery lesions: Rationale and study design

✍ Roberto Diletti; Patrick W. Serruys; Vasim Farooq; Krishnankutty Sudhir; Cecile 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 419 KB

A randomized two-by-two comparison of hi

A randomized two-by-two comparison of high-dose bolus tirofiban versus abciximab and unfractionated heparin versus bivalirudin during percutaneous coronary revascularization and stent placement: The tirofiban evaluation of novel dosing versus abciximab with clopidogrel and inhibition of thrombin (TENACITY) study trial

✍ David J. Moliterno;; the TENACITY Steering Committee; Investigators 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 200 KB 👁 1 views